Iptacopan hydrochloride, CAS [[1646321-63-2]]
Artikelnummer:
BYT-ORB1298299
- Bilder (0)
| Artikelname: | Iptacopan hydrochloride, CAS [[1646321-63-2]] |
| Artikelnummer: | BYT-ORB1298299 |
| Hersteller Artikelnummer: | orb1298299 |
| Alternativnummer: | BYT-ORB1298299-1, BYT-ORB1298299-1, BYT-ORB1298299-10, BYT-ORB1298299-100, BYT-ORB1298299-2, BYT-ORB1298299-200, BYT-ORB1298299-25, BYT-ORB1298299-5, BYT-ORB1298299-50 |
| Hersteller: | Biorbyt |
| Kategorie: | Biochemikalien |
| Alternative Synonym: | factor B, Inhibitor, hemolytic, hemoglobinuria, nocturnal, paroxysmal, pathogenesis, pathway, Iptacopan hydrochloride, Iptacopan Hydrochloride, Iptacopan HCl, Iptacopan, inhibit, LNP-023, LNP023 hydrochloride, LNP023 Hydrochloride, LNP-023 Hydrochloride, LNP 023, LNP 023 Hydrochloride, LNP023, alternative, atypical, Complement System, ComplementSystem, complement, system, syndrome, PNH, uremic |
| Iptacopan hydrochloride (LNP023 hydrochloride) is a potent, selective, and orally active inhibitor of human factor B, exhibiting high-affinity reversible binding with a KD of 7.9 nM and an IC50 of 10 nM. It is a valuable research tool for studying the alternative complement pathway in both in vitro assays and in vivo disease models. |
| Molekulargewicht: | 458.98 |
| Reinheit: | 99.89% (May vary between batches) |
| CAS Nummer: | [1646321-63-2] |
| Formel: | C25H31ClN2O4 |
| Target-Kategorie: | Complement System |
| Anwendungsbeschreibung: | Solubility: DMSO:252 mg/mL (549.04 mM),10% DMSO+40% PEG300+5% Tween 80+45% Saline:5 mg/mL (10.89 mM),H2O:50 mg/mL (108.94 mM) |
